Nevertheless, gp96 knockdown negatively affected the anti-myeloma activity of PU-H71 suggesting that the acute cytotoxic effect of HSP90 inhibitors is mediated through modulating both cytosolic HSP90 in addition to gp96 in the ER. The gene discussed is HSP90AB1; the disease is plasma cell myeloma.